These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 9819017

  • 1. A study of losartan, alone or with hydrochlorothiazide vs nifedipine GITS in elderly patients with diastolic hypertension.
    Conlin PR, Elkins M, Liss C, Vrecenak AJ, Barr E, Edelman JM.
    J Hum Hypertens; 1998 Oct; 12(10):693-9. PubMed ID: 9819017
    [Abstract] [Full Text] [Related]

  • 2. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
    Weir MR, Elkins M, Liss C, Vrecenak AJ, Barr E, Edelman JM.
    Clin Ther; 1996 Oct; 18(3):411-28. PubMed ID: 8829017
    [Abstract] [Full Text] [Related]

  • 3. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.
    Dey HM, Soufer R, Hoffer P, Wackers FJ, Black HR.
    Am J Hypertens; 1996 Jun; 9(6):598-606. PubMed ID: 8783785
    [Abstract] [Full Text] [Related]

  • 4. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.
    Oparil S, Barr E, Elkins M, Liss C, Vrecenak A, Edelman J.
    Clin Ther; 1996 Jun; 18(4):608-25. PubMed ID: 8879890
    [Abstract] [Full Text] [Related]

  • 5. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension.
    Townsend R, Haggert B, Liss C, Edelman JM.
    Clin Ther; 1995 Nov; 17(5):911-23. PubMed ID: 8595643
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy of various anti-hypertensive regimens in hypertensive women of Punjab; a longitudinal cohort study.
    Umair M, Ahmad M, Saeed H, Saleem Z, Tauqeer F.
    BMC Womens Health; 2020 Aug 01; 20(1):161. PubMed ID: 32738879
    [Abstract] [Full Text] [Related]

  • 8. A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and losartan 50 mg/hydrochlorothiazide 12.5 mg in the treatment of moderate-to-severe essential hypertension.
    Gradman AH, Brady WE, Gazdick LP, Lyle P, Zeldin RK.
    Clin Ther; 2002 Jul 01; 24(7):1049-61. PubMed ID: 12182251
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of long-acting nifedipine GITS/OROS monotherapy or combination therapy in hypertensive patients: results of a 12-week international, prospective, multicentre, observational study.
    Ueng KC, Ningling S, El Maksod A, Hung KY, Yuehui Y.
    Clin Drug Investig; 2011 Jul 01; 31(9):631-42. PubMed ID: 21591818
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of combination therapy with nifedipine GITS: a prospective, 12-week observational study (AdADOSE).
    Motaweih AK, Usova E, Hussain W, Dello Z, Schmidt B, Petri T.
    BMC Cardiovasc Disord; 2015 May 09; 15():35. PubMed ID: 25956918
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
    Oparil S, Aurup P, Snavely D, Goldberg A.
    Am J Cardiol; 2001 Mar 15; 87(6):721-6. PubMed ID: 11249890
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul 15; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 13. Blood pressure control in patients with mild to moderate essential hypertension switched from nifedipine gastrointestinal therapeutic system (GITS) 30 mg to nifedipine GITS 20 mg.
    Toal CB, Canadian Investigators.
    Clin Ther; 2001 Jan 15; 23(1):87-96. PubMed ID: 11219482
    [Abstract] [Full Text] [Related]

  • 14. Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension.
    Flack JM, Saunders E, Gradman A, Kraus WE, Lester FM, Pratt JH, Alderman M, Green S, Vargas R, Espenshade M, Ceesay P, Alexander J, Goldberg A, Study Group for Losartan in African Americans with Hypertension.
    Clin Ther; 2001 Aug 15; 23(8):1193-208. PubMed ID: 11558858
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.
    Oparil S, Abate N, Chen E, Creager MA, Galet V, Jia G, Julius S, Lerman A, Lyle PA, Pool J, Tershakovec AM.
    Curr Med Res Opin; 2008 Apr 15; 24(4):1101-14. PubMed ID: 18328120
    [Abstract] [Full Text] [Related]

  • 16. Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study.
    Wright RF, Duprez D, Purkayastha D, Samuel R, Ferdinand KC.
    J Clin Hypertens (Greenwich); 2011 Aug 15; 13(8):588-97. PubMed ID: 21806769
    [Abstract] [Full Text] [Related]

  • 17. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB, Reilly PA.
    Clin Ther; 2001 Jun 15; 23(6):833-50. PubMed ID: 11440284
    [Abstract] [Full Text] [Related]

  • 18. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
    Naidoo DP, Sareli P, Marin F, Aroca-Martinez G, Maritz FJ, Jardim PC, Guerrero AA, Thompson CA, Bero T, Drazka J, Kosmalova V, Dumortier T, Smith RD.
    Adv Ther; 1999 Jun 15; 16(5):187-99. PubMed ID: 10915394
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 15; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 20. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP, Joglekar SJ, Mukherjee S, Nanivadekar AS.
    J Assoc Physicians India; 1998 May 15; Suppl 1():30-40. PubMed ID: 11233385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.